Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
Appointed COO
Appointed director
VERACYTE, INC. (VCYT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "PRESS RELEASE 08.08.2023"
02/22/2023 8-K Quarterly results
Docs: "Veracyte Announces Fourth Quarter and Full-Year 2022 Financial Results"
08/02/2022 8-K Quarterly results
Docs: "PRESS RELEASE 08-02-2022"
05/03/2022 8-K Quarterly results
02/28/2022 8-K Quarterly results
11/09/2021 8-K Quarterly results
Docs: "PRESS RELEASE 11-09-2021"
07/29/2021 8-K Quarterly results
Docs: "PRESS RELEASE 07.29.2021"
05/10/2021 8-K Quarterly results
02/17/2021 8-K Quarterly results
11/02/2020 8-K Quarterly results
Docs: " "
07/30/2020 8-K Quarterly results
05/06/2020 8-K Quarterly results
02/25/2020 8-K Quarterly results
10/22/2019 8-K Quarterly results
07/30/2019 8-K Quarterly results
04/30/2019 8-K Quarterly results
Docs: "VCYT-04.30.19-8K-"
02/25/2019 8-K Quarterly results
10/29/2018 8-K Quarterly results
Docs: "VCYT - 8-K 10.29.18"
07/23/2018 8-K Quarterly results
Docs: "VCYT - 8-K 7.23.18"
05/01/2018 8-K Quarterly results
Docs: "VCYT - 8-K 5.1.18"
02/27/2018 8-K Quarterly results
Docs: "VCYT - 8-K 2.27.18"
07/31/2017 8-K Form 8-K - Current report:
05/03/2017 8-K Form 8-K - Current report
11/03/2016 8-K Form 8-K - Current report
08/03/2016 8-K Form 8-K - Current report
05/05/2016 8-K Quarterly results
Docs: "Veracyte Announces First Quarter 2016 Financial Results"
11/05/2015 8-K Quarterly results
Docs: "Veracyte Announces Third Quarter 2015 Financial Results"
08/13/2015 8-K Quarterly results
Docs: "Veracyte Announces Second Quarter 2015 Financial Results Revenue Increased 37% Compared to Second Quarter 2014"
05/14/2015 8-K Quarterly results
Docs: "Veracyte Announces First Quarter 2015 Financial Results"
11/13/2014 8-K Quarterly results
Docs: "Veracyte, Inc. Announces Third Quarter 2014 Financial Results — 3Q Revenue of $9.8 Million, a 76% Year-Over-Year Increase — — Established In-Network Contracts with UnitedHealthcare and Cigna for Afirma — — Accelerated Entry into Pulmonology Market with Allegro Diagnostics Acquisition — — Conference Call and Webcast Today at 5 p.m. ET"
08/13/2014 8-K Quarterly results
Docs: "Veracyte, Inc. Announces Second Quarter 2014 Financial Results — 2Q Revenue Increased 71%, Compared to Prior Year — — Company Announces Agreement to Amend Terms of Genzyme Co-Promotion Agreement — — Conference Call and Webcast Today at 5 p.m. ET"
05/08/2014 8-K Quarterly results
Docs: "Veracyte, Inc. Announces First Quarter 2014 Financial Results — 1Q Revenue Increased 71%, Compared to Prior Year — — First Blue Cross Plan Issues Coverage for Afirma® Gene Expression Classifier ; Total Covered Lives Exceeds 125 Million — — Conference Call and Webcast Today at 5 p.m. ET"
11/25/2013 8-K Quarterly results
Docs: "Veracyte, Inc. Announces Third Quarter 2013 Financial Results — 3Q Revenue Reached $5.6 Million, Increasing 74% Compared to Prior Year — — Coverage and Reimbursement Continue to Expand for Afirma® Gene Expression Classifier — — Company Successfully Completed Initial Public Offering on November 4 — — Conference Call Today at 5 p.m. ET"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy